Form D · Pharmaceuticals
Windhoek Rx Fund I, LLC
Medford, X1 · CIK 0001495244
Offering snapshot reported Jul 13, 2010 · SEC filing
- Reported sold
- $150K Offering amount: $4.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $30K Reported outside-investor minimum
- First sale
- Jul 9, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2010 | Initial | $150,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-144851
The securities are being offered directly to prospective investors without the assistance of any third party sales activity.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Windhoek Rx Fund I, LLC | None |
Source: Form D, filed Jul 13, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Akman | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
617 Stokes Rd, Suite 4 282
Medford, X1, 08055
Medford, X1, 08055